Immunoprophylaxis and immunotherapy of EL4 lymphoma.
D000818:Animals; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D002460:Cell Line; D005260:Female; D007114:Immunization; D007116:Immunization, Passive; D007167:Immunotherapy; D008223:Lymphoma / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000628:therapy; D011830:Radiation Effects; D013997:Time Factors
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001500:BCG Vaccine